148 related articles for article (PubMed ID: 1540900)
21. Suppressor gene alterations in the colorectal adenoma-carcinoma sequence.
Cho KR; Vogelstein B
J Cell Biochem Suppl; 1992; 16G():137-41. PubMed ID: 1469893
[TBL] [Abstract][Full Text] [Related]
22. [Cytomolecular aspects of colorectal carcinoma].
Miki Y; Nishisho I; Miyoshi Y; Nakamura Y
Gan To Kagaku Ryoho; 1991 Apr; 18(4):515-21. PubMed ID: 1849388
[TBL] [Abstract][Full Text] [Related]
23. Multistep carcinogenesis in colorectal cancers.
Takami K; Yana I; Kurahashi H; Nishisho I
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():190-6. PubMed ID: 8629105
[TBL] [Abstract][Full Text] [Related]
24. [Genetic analysis of adenomatous polyposis coli: analysis of alterations of oncogenes and tumor suppressor genes in colorectal tumors].
Toshitani K
Fukuoka Igaku Zasshi; 1992 Feb; 83(2):96-106. PubMed ID: 1317336
[TBL] [Abstract][Full Text] [Related]
25. The cellular and molecular pathogenesis of colorectal cancer.
Carethers JM
Gastroenterol Clin North Am; 1996 Dec; 25(4):737-54. PubMed ID: 8960890
[TBL] [Abstract][Full Text] [Related]
26. Biological consequences of the genetic changes which occur during human colorectal carcinogenesis.
Williams AC; Browne SJ; Manning AM; Hague A; van der Stappen JW; Paraskeva C
Semin Cancer Biol; 1993 Jun; 4(3):153-9. PubMed ID: 8318691
[TBL] [Abstract][Full Text] [Related]
27. Suppressor genes in breast cancer: an overview.
Steeg PS
Cancer Treat Res; 1992; 61():45-57. PubMed ID: 1360244
[TBL] [Abstract][Full Text] [Related]
28. Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma.
Williams AC; Browne SJ; Yeudal WA; Paterson IC; Marshall CJ; Lane DP; Paraskeva C
Oncogene; 1993 Nov; 8(11):3063-72. PubMed ID: 8414507
[TBL] [Abstract][Full Text] [Related]
29. Genetics of colorectal cancer (Review).
Peddanna N; Mendis R; Holt S; Verma R
Int J Oncol; 1996 Aug; 9(2):327-35. PubMed ID: 21541519
[TBL] [Abstract][Full Text] [Related]
30. Genetic alterations underlying colorectal tumorigenesis.
Fearon ER
Cancer Surv; 1992; 12():119-36. PubMed ID: 1638544
[TBL] [Abstract][Full Text] [Related]
31. Allelic loss at chromosomes 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer.
Li X; Lee NK; Ye YW; Waber PG; Schweitzer C; Cheng QC; Nisen PD
J Natl Cancer Inst; 1994 Oct; 86(20):1524-9. PubMed ID: 7932807
[TBL] [Abstract][Full Text] [Related]
32. Tumour suppressor genes and colorectal neoplasia.
Koorey DJ; McCaughan GW
J Gastroenterol Hepatol; 1993; 8(2):174-84. PubMed ID: 8471756
[TBL] [Abstract][Full Text] [Related]
33. Detection of DCC and Ki-ras gene alterations in colorectal carcinoma tissue as prognostic markers for liver metastatic recurrence.
Kato M; Ito Y; Kobayashi S; Isono K
Cancer; 1996 Apr; 77(8 Suppl):1729-35. PubMed ID: 8608570
[TBL] [Abstract][Full Text] [Related]
34. [Genetic alterations in localized cancers of the prostate: identification of a common region of deletion on the chromosome 18q].
Latil A; Baron JC; Cussenot O; Fournier G; Soussi T; Boccon-Gibod L; Le Duc A; Rouëssé J; Lidereau R
Bull Cancer; 1995 Jul; 82(7):589-97. PubMed ID: 7549122
[TBL] [Abstract][Full Text] [Related]
35. ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition.
Herbst A; Bommer GT; Kriegl L; Jung A; Behrens A; Csanadi E; Gerhard M; Bolz C; Riesenberg R; Zimmermann W; Dietmaier W; Wolf I; Brabletz T; Göke B; Kolligs FT
Gastroenterology; 2009 Aug; 137(2):639-48, 648.e1-9. PubMed ID: 19394332
[TBL] [Abstract][Full Text] [Related]
36. Low frequency and late occurrence of p53 and dcc aberrations in colorectal tumours.
Froggatt NJ; Leveson SH; Garner RC
J Cancer Res Clin Oncol; 1995; 121(1):7-15. PubMed ID: 7860623
[TBL] [Abstract][Full Text] [Related]
37. [Oncogenes and tumor suppressor genes: genetic changes mark the adenoma-carcinoma sequence].
Schmiegel WH
Internist (Berl); 1991 Jun; 32(6):315-20. PubMed ID: 1652573
[No Abstract] [Full Text] [Related]
38. [Genetic alterations and molecular mechanisms underlying colorectal tumorigenesis].
Ronchetto F
Minerva Med; 1998 May; 89(5):163-8. PubMed ID: 9676181
[TBL] [Abstract][Full Text] [Related]
39. Genetic pathways in the evolution of morphologically distinct colorectal neoplasms.
Yashiro M; Carethers JM; Laghi L; Saito K; Slezak P; Jaramillo E; Rubio C; Koizumi K; Hirakawa K; Boland CR
Cancer Res; 2001 Mar; 61(6):2676-83. PubMed ID: 11289147
[TBL] [Abstract][Full Text] [Related]
40. Recurrent deletions involving chromosomes 1, 5, 17, and 18 in colorectal carcinoma: possible role in biological and clinical behavior of tumors.
Gerdes H; Chen Q; Elahi AH; Sircar A; Goldberg E; Winawer D; Urmacher C; Winawer SJ; Jhanwar SC
Anticancer Res; 1995; 15(1):13-24. PubMed ID: 7733622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
